Improve radiology reporting efficiency and report quality with Imorgon's reporting automation.
As the top DICOM SR software for radiology, our solution significantly reduces unnecessary dictation by precisely transferring ultrasound and DEXA modality measurements into Powerscribe, Fluency, or RadAI. This eliminates manual errors and significantly accelerates the generation of reports.
Imorgon's unique advantages include:
- guaranteed transfer of all measurements - usually DICOM SR
- electronic worksheets for direct report population (eliminating dictation from notes)
- worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc)
- integration with Epic and other EHRs.
- vendor-neutral
Our dedicated support team ensures uninterrupted workflow.
Invest in Imorgon for a quick and substantial return on investment, transforming your reporting overhead into a streamlined, high-quality operation.
Learn more

TeleRay is an industry-first telehealth and image management platform. TeleRay cloud-based medical image management platform allows users to securely share images with professionals (specialists, referring, clinicians) and patients. The platform has many features, including the ability to import or convert DICOM or non DICOM images, query and HL7 connectivity. Integrate with any EMR, view images on an FDA approved viewer anywhere on any device.
Complete DICOM image migration is available- set up, training, and implementation is included. Live streaming and remote control of modalities are options and great for many use cases to place professionals virtually in a room any where.
TeleRay is the most secure platform with peer 2 peer health and data communication. You can use the app to access workflow tools like waiting rooms, multi-calls, call transfer and sharing of images. It's simple and affordable.
More than 3000 locations use our service, including 38 of the top medical centers in more than 20 nations. Get started today for free.
Learn more
Oncoustics
Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.
Learn more
Elements Contrast Clearance Analysis
Brainlab's Elements Contrast Clearance Analysis is an MRI-based technique aimed at distinguishing areas of contrast clearance and accumulation within brain tumor imaging datasets. This advanced high-resolution analysis enhances the understanding required for ongoing evaluations and decision-making across various clinical fields, including radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The methodology entails capturing two standard 3D T1-weighted MRIs; the first scan is taken around 5 minutes after administering a standard dose of contrast agent, while the second scan occurs 60 to 105 minutes later. By subtracting the initial series from the subsequent one, volumetric maps are created that clearly identify zones of contrast clearance (shown in blue) against those of contrast accumulation (illustrated in red). These findings empower clinicians to better evaluate the effects of radiation treatment in contrast to potential tumor regrowth, allowing for more educated decisions regarding both initial and subsequent treatment plans. As a result, this analysis not only aids in clinical assessments but also enhances the overall management of patient care in complex cases.
Learn more